382
LENZ Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
275
FY23:
67.2
FY24:
212
FY25:
301
(positive)
Change from FY21 to FY25
millions USD
FY21:
20.3
FY22:
46.5
FY23:
3.13
FY24:
3.39
FY25:
4.46
Total assets
Change from FY21 to FY25
millions USD
FY21:
402
FY22:
322
FY23:
70.4
FY24:
215
FY25:
306
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
12.1
FY22:
13.0
FY23:
18.5
FY24:
10.4
FY25:
21.2
(negative)
Change from FY21 to FY25
millions USD
FY21:
5.79
FY22:
12.6
FY23:
1.18
FY24:
0.81
FY25:
0.35
(positive)
Change from FY21 to FY25
millions USD
FY21:
384
FY22:
296
FY23:
−92.7
FY24:
204
FY25:
284
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
402
FY22:
322
FY23:
–
FY24:
215
FY25:
306
All amounts in millions USD